Integer Holdings Corporation (ITGR)
NYSE: ITGR · Real-Time Price · USD
69.84
-0.78 (-1.10%)
At close: Dec 5, 2025, 4:00 PM EST
69.25
-0.59 (-0.84%)
After-hours: Dec 5, 2025, 7:41 PM EST
Integer Holdings Market Cap
Integer Holdings has a market cap or net worth of $2.45 billion as of December 5, 2025. Its market cap has decreased by -45.36% in one year.
Market Cap
2.45B
Enterprise Value
3.70B
1-Year Change
-45.36%
Ranking
Category
Stock Price
$69.84
Market Cap Chart
Since September 29, 2000, Integer Holdings's market cap has increased from $408.50M to $2.45B, an increase of 499.04%. That is a compound annual growth rate of 7.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 2.45B | -44.95% |
| Dec 31, 2024 | 4.45B | 34.62% |
| Dec 29, 2023 | 3.30B | 45.58% |
| Dec 30, 2022 | 2.27B | -19.74% |
| Dec 31, 2021 | 2.83B | 5.88% |
| Dec 31, 2020 | 2.67B | 1.55% |
| Dec 31, 2019 | 2.63B | 6.43% |
| Dec 31, 2018 | 2.47B | 72.14% |
| Dec 29, 2017 | 1.43B | 57.87% |
| Dec 30, 2016 | 908.70M | -43.36% |
| Dec 31, 2015 | 1.60B | 30.19% |
| Dec 31, 2014 | 1.23B | 15.41% |
| Dec 31, 2013 | 1.07B | 93.90% |
| Dec 31, 2012 | 550.70M | 6.37% |
| Dec 30, 2011 | 517.70M | -7.90% |
| Dec 31, 2010 | 562.10M | 26.03% |
| Dec 31, 2009 | 446.00M | -26.44% |
| Dec 31, 2008 | 606.30M | 34.94% |
| Dec 31, 2007 | 449.30M | -24.18% |
| Dec 29, 2006 | 592.60M | 5.26% |
| Dec 30, 2005 | 563.00M | 17.39% |
| Dec 31, 2004 | 479.60M | -46.43% |
| Dec 31, 2003 | 895.20M | 46.01% |
| Dec 31, 2002 | 613.10M | -18.28% |
| Dec 31, 2001 | 750.20M | 40.96% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 924.69B |
| Johnson & Johnson | 496.44B |
| AbbVie | 407.51B |
| UnitedHealth Group | 309.03B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 255.18B |
| Thermo Fisher Scientific | 218.36B |